Tuberculose multirresistente.

In Western Europe, Portugal has the highest incidence of tuberculosis (TB) as well as HIV infection. At the Department of Infectious Diseases, Hospital de Santa Maria, Lisbon, we have observed a steady increase in cases of drug resistant (DR) and multi-drug resistant (MDR) TB over the last few years...

Full description

Bibliographic Details
Main Authors: Carolina Arez Constant, Pedro Bravo Ferreira, Emília Valadas, Francisco Antunes
Format: Article
Language:English
Published: Ordem dos Médicos 2004-04-01
Series:Acta Médica Portuguesa
Online Access:https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1653
_version_ 1811242444019204096
author Carolina Arez Constant
Pedro Bravo Ferreira
Emília Valadas
Francisco Antunes
author_facet Carolina Arez Constant
Pedro Bravo Ferreira
Emília Valadas
Francisco Antunes
author_sort Carolina Arez Constant
collection DOAJ
description In Western Europe, Portugal has the highest incidence of tuberculosis (TB) as well as HIV infection. At the Department of Infectious Diseases, Hospital de Santa Maria, Lisbon, we have observed a steady increase in cases of drug resistant (DR) and multi-drug resistant (MDR) TB over the last few years. To identify the determinants of drug- resistant tuberculosis, clinical notes from all patients admitted to the Department of Infectious Diseases from 1995 to 2000, with DR- or MDR-TB were retrospectively reviewed. A total of 212 samples, from 190 patients with tuberculosis were tested for sensitivity to first line anti-TB drugs, using standard methods. Most patients (61%) were intravenous drugs users. Resistance to at least one drug was found in 44 patients (23%); notes were available for review in 39 (36 HIV infected) patients. The rate of DR-TB was 9% (n=16) and that of MDR-TB was 15% (n=28). Almost half of the MDR-TB cases (n=13) showed resistance to four drugs (HRSE). Thirteen patients (69%) were first diagnosed as fully sensitive tuberculosis, during their first admission to the Department; however, later on they developed MDR-TB or DR-TB. Non-compliance with therapy and the intravenous use of drugs were associated with MDR-TB. The large increase in MDR-TB in our Department is of great concern. The clustering of identical resistance patterns suggest transmission of TB from a single source patient that may well have occurred in a nosocomial context. Traditional tuberculosis control measures seem to be insufficient in settings were prevalence of HIV infection and tuberculosis are high. This becomes even more important when the incidence of intravenous substance abuse, and often non-compliance, are predominant factors. Appropriate isolation facilities for all suspected tuberculosis cases as well as rapid diagnostic and drug susceptibility tests will be required to prevent further spread of MDR-TB.
first_indexed 2024-04-12T13:51:21Z
format Article
id doaj.art-a0d1aecf380a4308900520334113fa15
institution Directory Open Access Journal
issn 0870-399X
1646-0758
language English
last_indexed 2024-04-12T13:51:21Z
publishDate 2004-04-01
publisher Ordem dos Médicos
record_format Article
series Acta Médica Portuguesa
spelling doaj.art-a0d1aecf380a4308900520334113fa152022-12-22T03:30:30ZengOrdem dos MédicosActa Médica Portuguesa0870-399X1646-07582004-04-0117210.20344/amp.1653Tuberculose multirresistente.Carolina Arez Constant0Pedro Bravo FerreiraEmília ValadasFrancisco AntunesServiço de Doenças Infecciosas, Hospital de Santa Maria, Lisboa.In Western Europe, Portugal has the highest incidence of tuberculosis (TB) as well as HIV infection. At the Department of Infectious Diseases, Hospital de Santa Maria, Lisbon, we have observed a steady increase in cases of drug resistant (DR) and multi-drug resistant (MDR) TB over the last few years. To identify the determinants of drug- resistant tuberculosis, clinical notes from all patients admitted to the Department of Infectious Diseases from 1995 to 2000, with DR- or MDR-TB were retrospectively reviewed. A total of 212 samples, from 190 patients with tuberculosis were tested for sensitivity to first line anti-TB drugs, using standard methods. Most patients (61%) were intravenous drugs users. Resistance to at least one drug was found in 44 patients (23%); notes were available for review in 39 (36 HIV infected) patients. The rate of DR-TB was 9% (n=16) and that of MDR-TB was 15% (n=28). Almost half of the MDR-TB cases (n=13) showed resistance to four drugs (HRSE). Thirteen patients (69%) were first diagnosed as fully sensitive tuberculosis, during their first admission to the Department; however, later on they developed MDR-TB or DR-TB. Non-compliance with therapy and the intravenous use of drugs were associated with MDR-TB. The large increase in MDR-TB in our Department is of great concern. The clustering of identical resistance patterns suggest transmission of TB from a single source patient that may well have occurred in a nosocomial context. Traditional tuberculosis control measures seem to be insufficient in settings were prevalence of HIV infection and tuberculosis are high. This becomes even more important when the incidence of intravenous substance abuse, and often non-compliance, are predominant factors. Appropriate isolation facilities for all suspected tuberculosis cases as well as rapid diagnostic and drug susceptibility tests will be required to prevent further spread of MDR-TB.https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1653
spellingShingle Carolina Arez Constant
Pedro Bravo Ferreira
Emília Valadas
Francisco Antunes
Tuberculose multirresistente.
Acta Médica Portuguesa
title Tuberculose multirresistente.
title_full Tuberculose multirresistente.
title_fullStr Tuberculose multirresistente.
title_full_unstemmed Tuberculose multirresistente.
title_short Tuberculose multirresistente.
title_sort tuberculose multirresistente
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1653
work_keys_str_mv AT carolinaarezconstant tuberculosemultirresistente
AT pedrobravoferreira tuberculosemultirresistente
AT emiliavaladas tuberculosemultirresistente
AT franciscoantunes tuberculosemultirresistente